Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity
•The humoral immune response elicited by GMMA is independent on the TLR2 engagement.•The absence of TLR4 engagement negatively affects the anti-GMMA antibody production, but the impact on antibody functionality is dependent on the GMMA type and the presence of Alum adjuvant.•The disruption of antige...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2022-10, Vol.40 (44), p.6305-6314 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6314 |
|---|---|
| container_issue | 44 |
| container_start_page | 6305 |
| container_title | Vaccine |
| container_volume | 40 |
| creator | Piccioli, Diego Alfini, Renzo Monaci, Valentina Arato, Vanessa Carducci, Martina Aruta, Maria Grazia Rossi, Omar Necchi, Francesca Anemona, Alessandra Bartolini, Erika Micoli, Francesca |
| description | •The humoral immune response elicited by GMMA is independent on the TLR2 engagement.•The absence of TLR4 engagement negatively affects the anti-GMMA antibody production, but the impact on antibody functionality is dependent on the GMMA type and the presence of Alum adjuvant.•The disruption of antigen presentation by FDC to cognate B cells negatively affects both antibody production and functionality when immunizing with GMMA, in absence or presence of Alum adjuvant.•The immunological mechanisms of GMMA immunogenicity has been studied by using mutant mice in which the mechanisms under investigation were disrupted.
GMMA has been proposed as a potent technology platform for the design of safe, effective and affordable vaccines. As GMMA are vesicles blebbing out of the outer membrane of Gram-negative bacteria, they contain lipopolysaccharides, lipoproteins and peptidoglycans that stimulate immune cells via Toll-like Receptors 4 (TLR4) or TLR2. Being basically nanoparticles, GMMA can be efficiently captured by Follicular Dendritic Cells (FDC) for antigen presentation to cognate B cells. GMMA have shown to be highly immunogenic in preclinical and clinical studies and the engagement of TLR4 and TLR2 or antigen presentation by FDC may have a prominent role in GMMA immunogenicity, which is well worth investigating. By using GMMA derived from Shigella sonnei and Salmonella Typhimurium, we show for the first time that the antigen presentation by FDC to cognate B cells plays a major role in the induction of an effective humoral immune response upon immunization with GMMA by using both models. The engagement of TLR4 is critical to elicit an optimal antibody production, but its effect on antibody functionality is dependent on GMMA type and is dispensable when immunizing with Alum adjuvant, whereas TLR2 does not have any role for GMMA immunogenicity. Our findings represent a substantial advancement of the knowledge on GMMA mode of action and shed a light on novel perspectives for the design of safer and more effective GMMA-based vaccines.
The study demonstrated that the antigen presentation by FDC to cognate B cells plays a major role for GMMA immunogenicity. |
| doi_str_mv | 10.1016/j.vaccine.2022.09.034 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2717687658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X22011422</els_id><sourcerecordid>2724994200</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-b98b52d5ddb4c46688df15063b83256bccfde2364439fc8fa8f0646fc4bbcddd3</originalsourceid><addsrcrecordid>eNqFkcuO0zAUhiMEYsrAI4AssRkWKb7FSVaoDExBmooNSOwsX05GrhK72E6lvgcPjEsDCzasLP36zs1fVb0keE0wEW_366MyxnlYU0zpGvdrzPijakW6ltW0Id3jaoWp4DUn-PtV9SylPca4YaR_Wl0xQVjbY7Kqfm58dg_g0SFCAp9VdsEjfUJ3YRydmUcV0QfwNrrsDDIwjgnlgEx48CoDer9ELqGDO4asRjSEiLbgIarRJbBoF-w8Qvqd72DSUXlAy9SEbra73eYNctM0-1ASZ1w-Pa-eDGpM8GJ5r6tvdx-_3n6q779sP99u7mvDepZr3Xe6obaxVnPDheg6O5AGC6Y7RhuhjRksUCY4Z_1gukF1AxZcDIZrbay17Lq6ufQ9xPBjhpTl5NL5oLJimJOkLWlF14qmK-jrf9B9mKMv2xWK8r7nFONCNRfKxJBShEEeoptUPEmC5Vmb3MtFmzxrk7iXRVupe7V0n_UE9m_VH08FeHcBoHzH0UGUyTjwBqyLYLK0wf1nxC9sU62-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724994200</pqid></control><display><type>article</type><title>Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Piccioli, Diego ; Alfini, Renzo ; Monaci, Valentina ; Arato, Vanessa ; Carducci, Martina ; Aruta, Maria Grazia ; Rossi, Omar ; Necchi, Francesca ; Anemona, Alessandra ; Bartolini, Erika ; Micoli, Francesca</creator><creatorcontrib>Piccioli, Diego ; Alfini, Renzo ; Monaci, Valentina ; Arato, Vanessa ; Carducci, Martina ; Aruta, Maria Grazia ; Rossi, Omar ; Necchi, Francesca ; Anemona, Alessandra ; Bartolini, Erika ; Micoli, Francesca</creatorcontrib><description>•The humoral immune response elicited by GMMA is independent on the TLR2 engagement.•The absence of TLR4 engagement negatively affects the anti-GMMA antibody production, but the impact on antibody functionality is dependent on the GMMA type and the presence of Alum adjuvant.•The disruption of antigen presentation by FDC to cognate B cells negatively affects both antibody production and functionality when immunizing with GMMA, in absence or presence of Alum adjuvant.•The immunological mechanisms of GMMA immunogenicity has been studied by using mutant mice in which the mechanisms under investigation were disrupted.
GMMA has been proposed as a potent technology platform for the design of safe, effective and affordable vaccines. As GMMA are vesicles blebbing out of the outer membrane of Gram-negative bacteria, they contain lipopolysaccharides, lipoproteins and peptidoglycans that stimulate immune cells via Toll-like Receptors 4 (TLR4) or TLR2. Being basically nanoparticles, GMMA can be efficiently captured by Follicular Dendritic Cells (FDC) for antigen presentation to cognate B cells. GMMA have shown to be highly immunogenic in preclinical and clinical studies and the engagement of TLR4 and TLR2 or antigen presentation by FDC may have a prominent role in GMMA immunogenicity, which is well worth investigating. By using GMMA derived from Shigella sonnei and Salmonella Typhimurium, we show for the first time that the antigen presentation by FDC to cognate B cells plays a major role in the induction of an effective humoral immune response upon immunization with GMMA by using both models. The engagement of TLR4 is critical to elicit an optimal antibody production, but its effect on antibody functionality is dependent on GMMA type and is dispensable when immunizing with Alum adjuvant, whereas TLR2 does not have any role for GMMA immunogenicity. Our findings represent a substantial advancement of the knowledge on GMMA mode of action and shed a light on novel perspectives for the design of safer and more effective GMMA-based vaccines.
The study demonstrated that the antigen presentation by FDC to cognate B cells plays a major role for GMMA immunogenicity.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2022.09.034</identifier><identifier>PMID: 36137901</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Antibodies ; Antigen Presentation ; Antigens ; Bacteria ; Dendritic Cells ; Dendritic Cells, Follicular ; FDC ; GMMA ; Gram-negative bacteria ; Immune response ; Immune response (humoral) ; Immune system ; Immunization ; Immunogenicity ; Immunological mechanisms ; Immunology ; Investigations ; Lipids ; Lipopolysaccharides ; Lipoproteins ; Lymphocytes B ; Membranes ; Mode of action ; Nanoparticles ; Peptidoglycans ; Proteins ; Rodents ; TLR2 ; TLR2 protein ; TLR4 ; TLR4 protein ; Toll-Like Receptor 2 ; Toll-Like Receptor 4 ; Toll-like receptors ; Vaccines</subject><ispartof>Vaccine, 2022-10, Vol.40 (44), p.6305-6314</ispartof><rights>2022 The Authors</rights><rights>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><rights>2022. The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-b98b52d5ddb4c46688df15063b83256bccfde2364439fc8fa8f0646fc4bbcddd3</citedby><cites>FETCH-LOGICAL-c393t-b98b52d5ddb4c46688df15063b83256bccfde2364439fc8fa8f0646fc4bbcddd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2724994200?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36137901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piccioli, Diego</creatorcontrib><creatorcontrib>Alfini, Renzo</creatorcontrib><creatorcontrib>Monaci, Valentina</creatorcontrib><creatorcontrib>Arato, Vanessa</creatorcontrib><creatorcontrib>Carducci, Martina</creatorcontrib><creatorcontrib>Aruta, Maria Grazia</creatorcontrib><creatorcontrib>Rossi, Omar</creatorcontrib><creatorcontrib>Necchi, Francesca</creatorcontrib><creatorcontrib>Anemona, Alessandra</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Micoli, Francesca</creatorcontrib><title>Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•The humoral immune response elicited by GMMA is independent on the TLR2 engagement.•The absence of TLR4 engagement negatively affects the anti-GMMA antibody production, but the impact on antibody functionality is dependent on the GMMA type and the presence of Alum adjuvant.•The disruption of antigen presentation by FDC to cognate B cells negatively affects both antibody production and functionality when immunizing with GMMA, in absence or presence of Alum adjuvant.•The immunological mechanisms of GMMA immunogenicity has been studied by using mutant mice in which the mechanisms under investigation were disrupted.
GMMA has been proposed as a potent technology platform for the design of safe, effective and affordable vaccines. As GMMA are vesicles blebbing out of the outer membrane of Gram-negative bacteria, they contain lipopolysaccharides, lipoproteins and peptidoglycans that stimulate immune cells via Toll-like Receptors 4 (TLR4) or TLR2. Being basically nanoparticles, GMMA can be efficiently captured by Follicular Dendritic Cells (FDC) for antigen presentation to cognate B cells. GMMA have shown to be highly immunogenic in preclinical and clinical studies and the engagement of TLR4 and TLR2 or antigen presentation by FDC may have a prominent role in GMMA immunogenicity, which is well worth investigating. By using GMMA derived from Shigella sonnei and Salmonella Typhimurium, we show for the first time that the antigen presentation by FDC to cognate B cells plays a major role in the induction of an effective humoral immune response upon immunization with GMMA by using both models. The engagement of TLR4 is critical to elicit an optimal antibody production, but its effect on antibody functionality is dependent on GMMA type and is dispensable when immunizing with Alum adjuvant, whereas TLR2 does not have any role for GMMA immunogenicity. Our findings represent a substantial advancement of the knowledge on GMMA mode of action and shed a light on novel perspectives for the design of safer and more effective GMMA-based vaccines.
The study demonstrated that the antigen presentation by FDC to cognate B cells plays a major role for GMMA immunogenicity.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Antigen Presentation</subject><subject>Antigens</subject><subject>Bacteria</subject><subject>Dendritic Cells</subject><subject>Dendritic Cells, Follicular</subject><subject>FDC</subject><subject>GMMA</subject><subject>Gram-negative bacteria</subject><subject>Immune response</subject><subject>Immune response (humoral)</subject><subject>Immune system</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Immunological mechanisms</subject><subject>Immunology</subject><subject>Investigations</subject><subject>Lipids</subject><subject>Lipopolysaccharides</subject><subject>Lipoproteins</subject><subject>Lymphocytes B</subject><subject>Membranes</subject><subject>Mode of action</subject><subject>Nanoparticles</subject><subject>Peptidoglycans</subject><subject>Proteins</subject><subject>Rodents</subject><subject>TLR2</subject><subject>TLR2 protein</subject><subject>TLR4</subject><subject>TLR4 protein</subject><subject>Toll-Like Receptor 2</subject><subject>Toll-Like Receptor 4</subject><subject>Toll-like receptors</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkcuO0zAUhiMEYsrAI4AssRkWKb7FSVaoDExBmooNSOwsX05GrhK72E6lvgcPjEsDCzasLP36zs1fVb0keE0wEW_366MyxnlYU0zpGvdrzPijakW6ltW0Id3jaoWp4DUn-PtV9SylPca4YaR_Wl0xQVjbY7Kqfm58dg_g0SFCAp9VdsEjfUJ3YRydmUcV0QfwNrrsDDIwjgnlgEx48CoDer9ELqGDO4asRjSEiLbgIarRJbBoF-w8Qvqd72DSUXlAy9SEbra73eYNctM0-1ASZ1w-Pa-eDGpM8GJ5r6tvdx-_3n6q779sP99u7mvDepZr3Xe6obaxVnPDheg6O5AGC6Y7RhuhjRksUCY4Z_1gukF1AxZcDIZrbay17Lq6ufQ9xPBjhpTl5NL5oLJimJOkLWlF14qmK-jrf9B9mKMv2xWK8r7nFONCNRfKxJBShEEeoptUPEmC5Vmb3MtFmzxrk7iXRVupe7V0n_UE9m_VH08FeHcBoHzH0UGUyTjwBqyLYLK0wf1nxC9sU62-</recordid><startdate>20221019</startdate><enddate>20221019</enddate><creator>Piccioli, Diego</creator><creator>Alfini, Renzo</creator><creator>Monaci, Valentina</creator><creator>Arato, Vanessa</creator><creator>Carducci, Martina</creator><creator>Aruta, Maria Grazia</creator><creator>Rossi, Omar</creator><creator>Necchi, Francesca</creator><creator>Anemona, Alessandra</creator><creator>Bartolini, Erika</creator><creator>Micoli, Francesca</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20221019</creationdate><title>Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity</title><author>Piccioli, Diego ; Alfini, Renzo ; Monaci, Valentina ; Arato, Vanessa ; Carducci, Martina ; Aruta, Maria Grazia ; Rossi, Omar ; Necchi, Francesca ; Anemona, Alessandra ; Bartolini, Erika ; Micoli, Francesca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-b98b52d5ddb4c46688df15063b83256bccfde2364439fc8fa8f0646fc4bbcddd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Antigen Presentation</topic><topic>Antigens</topic><topic>Bacteria</topic><topic>Dendritic Cells</topic><topic>Dendritic Cells, Follicular</topic><topic>FDC</topic><topic>GMMA</topic><topic>Gram-negative bacteria</topic><topic>Immune response</topic><topic>Immune response (humoral)</topic><topic>Immune system</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Immunological mechanisms</topic><topic>Immunology</topic><topic>Investigations</topic><topic>Lipids</topic><topic>Lipopolysaccharides</topic><topic>Lipoproteins</topic><topic>Lymphocytes B</topic><topic>Membranes</topic><topic>Mode of action</topic><topic>Nanoparticles</topic><topic>Peptidoglycans</topic><topic>Proteins</topic><topic>Rodents</topic><topic>TLR2</topic><topic>TLR2 protein</topic><topic>TLR4</topic><topic>TLR4 protein</topic><topic>Toll-Like Receptor 2</topic><topic>Toll-Like Receptor 4</topic><topic>Toll-like receptors</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piccioli, Diego</creatorcontrib><creatorcontrib>Alfini, Renzo</creatorcontrib><creatorcontrib>Monaci, Valentina</creatorcontrib><creatorcontrib>Arato, Vanessa</creatorcontrib><creatorcontrib>Carducci, Martina</creatorcontrib><creatorcontrib>Aruta, Maria Grazia</creatorcontrib><creatorcontrib>Rossi, Omar</creatorcontrib><creatorcontrib>Necchi, Francesca</creatorcontrib><creatorcontrib>Anemona, Alessandra</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Micoli, Francesca</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piccioli, Diego</au><au>Alfini, Renzo</au><au>Monaci, Valentina</au><au>Arato, Vanessa</au><au>Carducci, Martina</au><au>Aruta, Maria Grazia</au><au>Rossi, Omar</au><au>Necchi, Francesca</au><au>Anemona, Alessandra</au><au>Bartolini, Erika</au><au>Micoli, Francesca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2022-10-19</date><risdate>2022</risdate><volume>40</volume><issue>44</issue><spage>6305</spage><epage>6314</epage><pages>6305-6314</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>•The humoral immune response elicited by GMMA is independent on the TLR2 engagement.•The absence of TLR4 engagement negatively affects the anti-GMMA antibody production, but the impact on antibody functionality is dependent on the GMMA type and the presence of Alum adjuvant.•The disruption of antigen presentation by FDC to cognate B cells negatively affects both antibody production and functionality when immunizing with GMMA, in absence or presence of Alum adjuvant.•The immunological mechanisms of GMMA immunogenicity has been studied by using mutant mice in which the mechanisms under investigation were disrupted.
GMMA has been proposed as a potent technology platform for the design of safe, effective and affordable vaccines. As GMMA are vesicles blebbing out of the outer membrane of Gram-negative bacteria, they contain lipopolysaccharides, lipoproteins and peptidoglycans that stimulate immune cells via Toll-like Receptors 4 (TLR4) or TLR2. Being basically nanoparticles, GMMA can be efficiently captured by Follicular Dendritic Cells (FDC) for antigen presentation to cognate B cells. GMMA have shown to be highly immunogenic in preclinical and clinical studies and the engagement of TLR4 and TLR2 or antigen presentation by FDC may have a prominent role in GMMA immunogenicity, which is well worth investigating. By using GMMA derived from Shigella sonnei and Salmonella Typhimurium, we show for the first time that the antigen presentation by FDC to cognate B cells plays a major role in the induction of an effective humoral immune response upon immunization with GMMA by using both models. The engagement of TLR4 is critical to elicit an optimal antibody production, but its effect on antibody functionality is dependent on GMMA type and is dispensable when immunizing with Alum adjuvant, whereas TLR2 does not have any role for GMMA immunogenicity. Our findings represent a substantial advancement of the knowledge on GMMA mode of action and shed a light on novel perspectives for the design of safer and more effective GMMA-based vaccines.
The study demonstrated that the antigen presentation by FDC to cognate B cells plays a major role for GMMA immunogenicity.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>36137901</pmid><doi>10.1016/j.vaccine.2022.09.034</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2022-10, Vol.40 (44), p.6305-6314 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2717687658 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Animals Antibodies Antigen Presentation Antigens Bacteria Dendritic Cells Dendritic Cells, Follicular FDC GMMA Gram-negative bacteria Immune response Immune response (humoral) Immune system Immunization Immunogenicity Immunological mechanisms Immunology Investigations Lipids Lipopolysaccharides Lipoproteins Lymphocytes B Membranes Mode of action Nanoparticles Peptidoglycans Proteins Rodents TLR2 TLR2 protein TLR4 TLR4 protein Toll-Like Receptor 2 Toll-Like Receptor 4 Toll-like receptors Vaccines |
| title | Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigen%20presentation%20by%20Follicular%20Dendritic%20cells%20to%20cognate%20B%20cells%20is%20pivotal%20for%20Generalised%20Modules%20for%20Membrane%20Antigens%20(GMMA)%20immunogenicity&rft.jtitle=Vaccine&rft.au=Piccioli,%20Diego&rft.date=2022-10-19&rft.volume=40&rft.issue=44&rft.spage=6305&rft.epage=6314&rft.pages=6305-6314&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2022.09.034&rft_dat=%3Cproquest_cross%3E2724994200%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724994200&rft_id=info:pmid/36137901&rft_els_id=S0264410X22011422&rfr_iscdi=true |